Pioglitazone use increases risk of Alzheimer's disease in patients with type 2 diabetes receiving insulin
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Pioglitazone use increases risk of Alzheimer's disease in patients with type 2 diabetes receiving insulin ; volume:13 ; number:1 ; day:24 ; month:4 ; year:2023 ; pages:1-9 ; date:12.2023
Scientific reports ; 13, Heft 1 (24.4.2023), 1-9, 12.2023
- Creator
-
Lin, Hsin-Chung
Chung, Chi-Hsiang
Chen, Lih-Chyang
Wang, Jui-Yang
Chen, Chien-Chou
Huang, Kuo-Yang
Tsai, Ming-Hang
Chien, Wu-Chien
Lin, Hsin-An
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-023-33674-2
- URN
-
urn:nbn:de:101:1-2023090209225036502290
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lin, Hsin-Chung
- Chung, Chi-Hsiang
- Chen, Lih-Chyang
- Wang, Jui-Yang
- Chen, Chien-Chou
- Huang, Kuo-Yang
- Tsai, Ming-Hang
- Chien, Wu-Chien
- Lin, Hsin-An
- SpringerLink (Online service)
Other Objects (12)
Intranasal Insulin for Alzheimer’s Disease
Pioglitazone Improved Insulin Sensitivity and First Phase Insulin Secretion Among Obese and Lean People with Diabetes: A Multicenter Clamp Study
Diabetes, insulin and Alzheimer's disease
Pioglitazone Ameliorates Intracerebral Insulin Resistance and Tau-protein Hyperphosphorylation in Rats with Type 2 Diabetes
Impairment of insulin signaling pathway in Alzheimer’s disease
Impairment of insulin signaling pathway in Alzheimer’s disease
Glycemic control in patients receiving insulin critics: integrative review
Glycemic control in patients receiving insulin critics: integrative review
Insulin Deficiency Increases Sirt2 Level in Streptozotocin-Treated Alzheimer’s Disease-Like Mouse Model: Increased Sirt2 Induces Tau Phosphorylation Through ERK Activation
Does insulin resistance influence neurodegeneration in non-diabetic Alzheimer’s subjects?
Randomized placebo control study of insulin sensitizers (Metformin and Pioglitazone) in psoriasis patients with metabolic syndrome (Topical Treatment Cohort)
Pioglitazone is effective for multiple phenotyepes of the Zucker fa/fa rat with polycystc ovary morphology and insulin resistance
Intranasal Insulin for Alzheimer’s Disease
Pioglitazone Improved Insulin Sensitivity and First Phase Insulin Secretion Among Obese and Lean People with Diabetes: A Multicenter Clamp Study
Diabetes, insulin and Alzheimer's disease
Pioglitazone Ameliorates Intracerebral Insulin Resistance and Tau-protein Hyperphosphorylation in Rats with Type 2 Diabetes
Impairment of insulin signaling pathway in Alzheimer’s disease
Impairment of insulin signaling pathway in Alzheimer’s disease
Glycemic control in patients receiving insulin critics: integrative review
Glycemic control in patients receiving insulin critics: integrative review
Insulin Deficiency Increases Sirt2 Level in Streptozotocin-Treated Alzheimer’s Disease-Like Mouse Model: Increased Sirt2 Induces Tau Phosphorylation Through ERK Activation
Does insulin resistance influence neurodegeneration in non-diabetic Alzheimer’s subjects?
Randomized placebo control study of insulin sensitizers (Metformin and Pioglitazone) in psoriasis patients with metabolic syndrome (Topical Treatment Cohort)
Pioglitazone is effective for multiple phenotyepes of the Zucker fa/fa rat with polycystc ovary morphology and insulin resistance
Intranasal Insulin for Alzheimer’s Disease
Pioglitazone Improved Insulin Sensitivity and First Phase Insulin Secretion Among Obese and Lean People with Diabetes: A Multicenter Clamp Study
Diabetes, insulin and Alzheimer's disease
Pioglitazone Ameliorates Intracerebral Insulin Resistance and Tau-protein Hyperphosphorylation in Rats with Type 2 Diabetes
Impairment of insulin signaling pathway in Alzheimer’s disease
Impairment of insulin signaling pathway in Alzheimer’s disease
Glycemic control in patients receiving insulin critics: integrative review
Glycemic control in patients receiving insulin critics: integrative review
Insulin Deficiency Increases Sirt2 Level in Streptozotocin-Treated Alzheimer’s Disease-Like Mouse Model: Increased Sirt2 Induces Tau Phosphorylation Through ERK Activation
Does insulin resistance influence neurodegeneration in non-diabetic Alzheimer’s subjects?
Randomized placebo control study of insulin sensitizers (Metformin and Pioglitazone) in psoriasis patients with metabolic syndrome (Topical Treatment Cohort)